TisCRT-LAPC: A phase II study of tislelizumab combined with nab-paclitaxel and gemcitabine (AG) followed by consolidative radiotherapy in locally advanced pancreatic cancer (LAPC). X Guo, Y Zhou, Y Ji, W Lou, L Wu, W Wang Journal of Clinical Oncology 42 (16_suppl), e16350-e16350, 2024 | | 2024 |
Consensus on the clinical diagnosis and treatment of grade 3 pancreatic neuroendocrine tumors J Chen, W Wu, C Bai, Y Chi, L Huo, L Jiang, Y Ji, J Luo, J Li, J Li, W Lou, ... Journal of Pancreatology 7 (2), 97-105, 2024 | | 2024 |
Identification of methylation driver genes for predicting the prognosis of pancreatic cancer patients based on whole-genome DNA methylation sequencing technology C Song, G Wang, M Liu, Z Xu, X Liang, K Ding, Y Chen, W Wang, W Lou, ... Heliyon 10 (9), 2024 | | 2024 |
Pancreatic surgery is safe in elder patients with PDAC Y Zhang, S Han, Y Xu, L Liu, W Wu, L Zhang, C Song, D Wang, W Lou | | 2024 |
Circulating cell‐free DNA methylation‐based multi‐omics analysis allows early diagnosis of pancreatic ductal adenocarcinoma G Zhao, R Jiang, Y Shi, S Gao, D Wang, Z Li, Y Zhou, J Sun, W Wu, ... Molecular Oncology, 2024 | 1 | 2024 |
Efficacy of nab‑paclitaxel vs. Gemcitabine in combination with S‑1 for advanced pancreatic cancer: A multicenter phase II randomized trial X Guo, W Lou, Y Xu, R Zhuang, L Yao, J Wu, D Fu, J Zhang, J Liu, Y Rong, ... Oncology Letters 27 (4), 1-11, 2024 | | 2024 |
Contrast-enhanced ultrasound (CEUS) and shear wave elastography (SWE) features for characterizing serous microcystic adenomas (SMAs): In comparison to pancreatic neuroendocrine … XF Tian, LY Yu, DH Yang, D Zuo, JY Cao, Y Wang, ZY Yang, WH Lou, ... Heliyon 10 (3), 2024 | | 2024 |
Characteristics of changes in plasma proteome profiling after sleeve gastrectomy Y Zhang, C Shi, H Wu, H Yan, M Xia, H Jiao, D Zhou, W Wu, M Zhong, ... Frontiers in Endocrinology 15, 1330139, 2024 | | 2024 |
The potential of siglecs and sialic acids as biomarkers and therapeutic targets in tumor immunotherapy H Feng, J Feng, X Han, Y Ying, W Lou, L Liu, L Zhang Cancers 16 (2), 289, 2024 | 2 | 2024 |
Poor clinical outcomes and immunoevasive contexture in CD161+ CD8+ T cells barren human pancreatic cancer Q Chen, H Yin, Z Jiang, T He, Y Xie, W Mao, J Han, S Liu, W Lou, W Wu, ... Journal for Immunotherapy of Cancer 12 (3), 2024 | | 2024 |
Unveiling Circulating Targets in Pancreatic Cancer: Insights from Proteogenomic Evidence and Clinical Cohorts H Feng, Z Chen, J Li, J Feng, F Yang, F Meng, H Yin, Y Guo, H Xu, Y Liu, ... medRxiv, 2024.02. 08.24302497, 2024 | | 2024 |
Chinese expert consensus on multidisciplinary diagnosis and treatment of pancreatic neuroendocrine liver metastases Y Chi, L Jiang, S Shi, S He, C Bai, D Cao, J Cai, Q Chen, X Chen, Y Deng, ... Journal of Pancreatology 6 (04), 139-150, 2023 | 2 | 2023 |
Survival outcomes of pancreaticoduodenectomy versus extended pancreaticoduodenectomy procedure for pancreatic head carcinoma: a propensity score matching study (vol 9, pg 1476 … N Pu, S Mu, Y Fang, H Yin, G Liu, G Zhao, L Zhang, W Wu, W Lou TRANSLATIONAL CANCER RESEARCH 12 (11), 3218-3219, 2023 | | 2023 |
Serum Interleukin-6 as a Biomarker for Early Prediction of Post-Operative Infectious Complications After Elective Pancreatectomy G Zhao, J Zhu, C Shi, D Wang, W Wu, T Kuang, W Guo, W Lou Surgical Infections 24 (9), 811-817, 2023 | 1 | 2023 |
Tumor Microenvironment Responsive CD8+ T Cells and Myeloid‐Derived Suppressor Cells to Trigger CD73 Inhibitor AB680‐Based Synergistic Therapy for … Q Chen, H Yin, J He, Y Xie, W Wang, H Xu, L Zhang, C Shi, J Yu, W Wu, ... Advanced Science 10 (33), 2302498, 2023 | 4 | 2023 |
Application of ultrasound shear wave elastography in pre-operative and quantitative prediction of clinically relevant post-operative pancreatic fistula after pancreatectomy: a … XF Tian, L Zhang, WH Lou, YJ Qiu, D Zuo, WP Wang, Y Dong European Radiology 33 (11), 7866-7876, 2023 | 4 | 2023 |
Preoperative ultrasound radiomics for predicting clinically relevant postoperative pancreatic fistula after pancreatectomy YL Huang, XF Tian, YJ Qiu, W Lou, EM Jung, Y Dong, HZ Wang, ... Clinical Hemorheology and Microcirculation, 1-14, 2023 | 1 | 2023 |
Baseline radiologic features as predictors of efficacy in patients with pancreatic neuroendocrine tumors with liver metastases receiving surufatinib J Zhang, H Zhu, L Shen, J Li, X Zhang, C Bai, Z Zhou, X Yu, Z Li, E Li, ... Chinese Journal of Cancer Research 35 (5), 526, 2023 | 1 | 2023 |
Survival benefit and impact of adjuvant chemotherapy following systemic neoadjuvant chemotherapy in patients with resected pancreas ductal adenocarcinoma: a retrospective … N Pu, W Wu, S Liu, Y Xie, H Yin, Q Chen, T He, Z Xu, W Wang, J Yu, L Liu, ... International Journal of Surgery 109 (10), 3137-3146, 2023 | 5 | 2023 |
Consensus of clinical diagnosis and treatment for non-functional pancreatic neuroendocrine neoplasms with diameter< 2 cm W Wu, S Cai, R Chen, D Fu, C Ge, C Hao, J Hao, H Huang, Z Jian, G Jin, ... Journal of Pancreatology 6 (03), 87-95, 2023 | | 2023 |